SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-009937
Filing Date
2019-05-15
Accepted
2019-05-15 09:38:47
Documents
55
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q relv20190331_10q.htm 10-Q 882309
2 EXHIBIT 31.1 ex_144116.htm EX-31.1 10981
3 EXHIBIT 31.2 ex_144117.htm EX-31.2 10958
4 EXHIBIT 32 ex_144118.htm EX-32 7727
  Complete submission text file 0001437749-19-009937.txt   4083982

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT relv-20190331.xml EX-101.INS 712761
6 XBRL TAXONOMY EXTENSION SCHEMA relv-20190331.xsd EX-101.SCH 42575
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE relv-20190331_cal.xml EX-101.CAL 52115
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE relv-20190331_def.xml EX-101.DEF 301102
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE relv-20190331_lab.xml EX-101.LAB 274458
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE relv-20190331_pre.xml EX-101.PRE 321964
Mailing Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405
Business Address 136 CHESTERFIELD INDUSTRIAL BLVD P O BOX 405 CHESTERFIELD MO 63006-0405 636-537-9715
RELIV INTERNATIONAL INC (Filer) CIK: 0000768710 (see all company filings)

IRS No.: 371172197 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19932 | Film No.: 19825520
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1